Agenda - March 30, 2004

President's Council of Advisors on Science and Technology

The St. Regis Hotel
Crystal Ballroom
923 16th St. NW
Washington, DC 20006

9:00 AM	Meeting Convenes
9:15 AM	Presentation and Discussion of Draft Report from Subcommittee on Science & Engineering Workforce/Education
11:45 AM	Break
1:00 PM	Environmental and Health Effects of Nanotechnology: Implications for Research,Commercialization, and Regulations -- Non-Government Perspectives Dr. Vicki Colvin, Rice University Research on Environmental and Health Effects Dr. Robert Gower, Carbon Nanotechnologies Inc. Commercialization of Nanomaterials: Perspectives of a Small Business Dr. David Diehl, PPG Industries Commercialization of Nanomaterials: Perspectives of a Large Business Mr. Josh Wolfe, Lux Capital Commercialization of Nanomaterials: Perspective of the Investor Community
3:00 PM	Environmental and Health Effects of Nanotechnology: Implications for Research,Commercialization, and Regulations -- Federal Government Perspectives Dr. Norris Alderson, FDA FDA Perspective on Regulating Nanomaterials Mr. Charles Auer, EPA EPA Perspective on Regulating Nanomaterials Dr. John Bucher, NIEHS Federal Toxicology Research: National Toxicology Program Dr. Clayton Teague, National Nanotechnology Coordination Office NNI Funding for Research on Environmental and Health Implications
4:45 PM	Public Presenters
5:00 PM	Meeting Adjourns